Home >> Signaling Pathways >> PI3K/Akt/mTOR Signaling >> PI4K


PI4K (phosphatidylinositol 4-kinase) catalyzes the first committed steps for phosphatidylinositol 4,5-bisphosphate biosynthesis. It is associated with viral replication and cancer.

  1. Cat.No. 产品名称 Information
  2. GC65454 UCT943
  3. GC65309 GSK-F1
  4. GC62109 MMV390048
  5. GC39155 PI-273 PI-273, the first reversibly and specific phosphatidylinositol 4-kinase (PI4KIIα) inhibitor with an IC50 of 0.47 μM, can inhibit breast cancer cell proliferation, block the cell cycle and induce cell apoptosis.
  6. GC38033 KDU731
  7. GC32847 PI4KIIIbeta-IN-9
  8. GC32381 BF738735
  9. GC32199 T-00127_HEV1
  10. GC32163 BQR-695 (NVP-BQR695) An antimalarial compound
  11. GC32118 KDU691 An antimalarial compound
  12. GC30777 PI4KIIIbeta-IN-10
  13. GC18164 UCB9608 UCB9608 是一种有效、选择性和口服活性的 PI4KIIIβ 抑制剂,IC50 为 11 nM,对 PI3KC2 α、β 和 γ 脂质激酶具有选择性。
  14. GC13089 PIK-93 A PI4KIIIβ inhibitor
  15. GC15508 PI4KIII beta inhibitor 3 PI4KIII beta inhibitor 3 是一种新型高效的 PI4KIIIβ 抑制剂,IC50 为 5.7 nM。

14 Item(s)

per page

Set Descending Direction